Literature DB >> 15724843

Human ATP-binding cassette transporter ABCC10: expression profile and p53-dependent upregulation.

Shin-Ichiro Takayanagi1, Takao Kataoka, Osamu Ohara, Michio Oishi, M Tien Kuo, Toshihisa Ishikawa.   

Abstract

Human ATP-binding cassette (ABC) transporter genes are classified into seven sub-families, where "C" subfamily comprises a total of 13 gene members. The ABCC10 cDNA was cloned in the human full-length cDNA project at the Kazusa DNA Research Institute. However, current information is limited regarding its physiological function and gene expression. In the present study, we have investigated the expression of the ABCC10 gene to gain insight into its biological nature. By quantitative PCR, ABCC10 gene expression is demonstrated to be highest in pancreas among the adult and fetal tissues and tumors presently tested. Decreased expression was observed when resting T- and B-cells were activated. Furthermore, when we examined its expression under apoptotic conditions, we found that ABCC10 mRNA levels remarkably increased in doxorubicin-treated MCF7 cells, whereas its up-regulation was suppressed in p53-dominant-negative MCF7 cells. These results suggest that expression of the ABCC10 gene is regulated in a p53-dependent manner during DNA-damage-related apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15724843

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  19 in total

1.  Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione.

Authors:  Heather M Brechbuhl; Remy Kachadourian; Elysia Min; Daniel Chan; Brian J Day
Journal:  Toxicol Appl Pharmacol       Date:  2011-08-10       Impact factor: 4.219

Review 2.  Multidrug Resistance Proteins (MRPs) and Cancer Therapy.

Authors:  Yun-Kai Zhang; Yi-Jun Wang; Pranav Gupta; Zhe-Sheng Chen
Journal:  AAPS J       Date:  2015-04-04       Impact factor: 4.009

3.  Molecular and structural characteristics of multidrug resistance-associated protein 7 in Chinese liver fluke Clonorchis sinensis.

Authors:  Fuhong Dai; Won Gi Yoo; Ji-Yun Lee; Yanyan Lu; Jhang Ho Pak; Woon-Mok Sohn; Sung-Jong Hong
Journal:  Parasitol Res       Date:  2017-01-05       Impact factor: 2.289

4.  Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.

Authors:  Elizabeth A Hopper-Borge; Timothy Churchill; Chelsy Paulose; Emmanuelle Nicolas; Joely D Jacobs; Olivia Ngo; Yehong Kuang; Alex Grinberg; Heiner Westphal; Zhe-Sheng Chen; Andres J Klein-Szanto; Martin G Belinsky; Gary D Kruh
Journal:  Cancer Res       Date:  2011-05-15       Impact factor: 12.701

Review 5.  ABCC10, ABCC11, and ABCC12.

Authors:  Gary D Kruh; Yanping Guo; Elizabeth Hopper-Borge; Martin G Belinsky; Zhe-Sheng Chen
Journal:  Pflugers Arch       Date:  2006-07-26       Impact factor: 3.657

6.  The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.

Authors:  April L Risinger; Evelyn M Jackson; Lisa A Polin; Gregory L Helms; Desiree A LeBoeuf; Patrick A Joe; Elizabeth Hopper-Borge; Richard F Ludueña; Gary D Kruh; Susan L Mooberry
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

7.  Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.

Authors:  Elizabeth Hopper-Borge; Xiu Xu; Tong Shen; Zhi Shi; Zhe-Sheng Chen; Gary D Kruh
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

8.  Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7).

Authors:  Ekaterina V Malofeeva; Natalya Domanitskaya; Mariya Gudima; Elizabeth A Hopper-Borge
Journal:  Cancer Res       Date:  2012-10-19       Impact factor: 12.701

9.  Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.

Authors:  Yue-Li Sun; Jun-Jiang Chen; Priyank Kumar; Kang Chen; Kamlesh Sodani; Atish Patel; Yang-Lu Chen; Si-Dong Chen; Wen-Qi Jiang; Zhe-Sheng Chen
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

10.  PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR.

Authors:  Nagaraju Anreddy; Atish Patel; Kamlesh Sodani; Rishil J Kathawala; Eugenie P Chen; John N D Wurpel; Zhe-Sheng Chen
Journal:  Acta Pharm Sin B       Date:  2014-03-29       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.